2,3-bis(3'-hydroxybenzyl)butyrolactone and Heart Disease, Ischemic

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with Heart Disease, Ischemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adlercreutz, H; Rissanen, TH; Salonen, JT; Vanharanta, M; Voutilainen, S	1

Other Studies

1 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Heart Disease, Ischemic

Article	Year
Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study. Archives of internal medicine, 2003, May-12, Volume: 163, Issue:9 Topics: 4-Butyrolactone; Adult; Cause of Death; Finland; Follow-Up Studies; Humans; Lignans; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Risk Assessment; Risk Factors	2003

Article

Year

Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study.

Archives of internal medicine, 2003, May-12, Volume: 163, Issue:9

Topics: 4-Butyrolactone; Adult; Cause of Death; Finland; Follow-Up Studies; Humans; Lignans; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Risk Assessment; Risk Factors

2003